...
首页> 外文期刊>Strahlentherapie und Onkologie >Metastatic spinal cord compression in non-small cell lung cancer patients : Prognostic factors in a series of 356?patients.
【24h】

Metastatic spinal cord compression in non-small cell lung cancer patients : Prognostic factors in a series of 356?patients.

机译:非小细胞肺癌患者的转移性脊髓压迫:356位患者的预后因素。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Patients with metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC) have an unfavorable prognosis compared to most other MSCC patients. This study was performed to identify prognostic factors for functional outcome and survival in these patients after radiotherapy (RT) alone. PATIENTS AND METHODS: Data of 356 patients irradiated for MSCC from NSCLC were retrospectively analyzed. Ten potential prognostic factors were investigated including age, gender, Eastern cooperative Oncology Group performance score (ECOG-PS), number of involved vertebrae, pre-RT ambulatory status, other bone metastases, visceral metastases, interval from cancer diagnosis to RT of MSCC, time developing motor deficits before RT, and the radiation schedule. RESULTS: On multivariate analysis, better functional outcome was associated with pre-RT ambulatory status (estimate: -?0.84, p?=?0.022), no visceral metastases (estimate: -?1.15, p??15?months (estimate:? +?0.48, p?=?0.019), and slower (>?7?days) development of motor deficits (estimate: ?+?1.56, p??15 months (RR 0.84, p?=?0.035), and slower (>?7?days) development of motor deficits (RR 0.78, p?
机译:背景:非小细胞肺癌(NSCLC)伴有转移性脊髓压迫症(MSCC)的患者与大多数其他MSCC患者相比预后不良。进行这项研究的目的是为了确定这些患者单独接受放疗(RT)后的功能结局和生存的预后因素。病人和方法:回顾性分析了356例经NSCLC照射的MSCC患者的数据。调查了十个潜在的预后因素,包括年龄,性别,东部合作肿瘤小组表现评分(ECOG-PS),受累椎骨数量,RT前动态状态,其他骨转移,内脏转移,从癌症诊断到MSCC的时间间隔,在RT之前出现运动障碍的时间,以及辐射时间表。结果:在多变量分析中,更好的功能结局与RT前的非卧床状态相关(估计:-?0.84,p?=?0.022),无内脏转移(估计:-?1.15,p?<?0.001),从癌症诊断到RT> 15个月(估计:+ 0.48,p = 0.019),运动障碍的发展较慢(> 7天)(估计:1.56,p <1.56,p =)。 0.001)。在多变量分析中,提高的生存率与女性性别(风险比(RR)1.32,p?=?0.043),ECOG-PS 1-2(RR 1.45,p?=?0.034),RT前非卧床状态显着相关( RR 0.58,p 0.001),无其他骨转移(RR 1.38,p <= 0.010),无内脏转移(RR 2.87,p 0.001),从癌症诊断到RT> 15个月(RR 0.84,p≤0.035),和运动障碍的发展较慢(≥7天)(RR 0.78,p≤0.001)。结论:本研究确定了NSCLC放疗MCCC后预后的其他独立预后因素。这些预后因素可在将来的试验中用于分层,有助于从NSCLC获得MSCC的预后评分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号